Skin manifestation of Stenotrophomonas maltophilia infection - A case report and review article

Annals of the Academy of Medicine Singapore

Volumn 35, Issue 12, 2006, Pages 897-900

  Teo, Wan Yee ^a,b   Chan, Mei Yoke ^a   Lam, Ching Mei ^a   Chong, Chia Yin ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b NONE   (Singapore)

Author keywords

Acute myeloid leukaemia; Mucocutaneous; Skin; Soft tissue; Stenotrophomonas maltophilia

Indexed keywords

AMIKACIN; AMPHOTERICIN; ANTINEOPLASTIC AGENT; CEFTAZIDIME; COTRIMOXAZOLE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; MEROPENEM; STEROID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; BACTEREMIA; BACTERIAL INFECTION; BLOOD CULTURE; CASE REPORT; CELLULITIS; CLINICAL FEATURE; DRUG SENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOPYON; LUNG ASPERGILLOSIS; NEUTROPENIA; REVIEW; SCHOOL CHILD; SEPTICEMIA; SKIN MANIFESTATION; SKIN METASTASIS; SKIN NECROSIS; SOFT TISSUE INFECTION; STENOTROPHOMONAS MALTOPHILIA; ACUTE DISEASE; ARTICLE; BACTERIAL SKIN DISEASE; CHILD; COMORBIDITY; GRAM NEGATIVE INFECTION; MICROBIOLOGY; MYELOID LEUKEMIA; PROGNOSIS;

ACUTE DISEASE; ANTI-INFECTIVE AGENTS; BACTEREMIA; CELLULITIS; CHILD; COMORBIDITY; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LEUKEMIA, MYELOID; NEUTROPENIA; PROGNOSIS; SKIN DISEASES, BACTERIAL; STENOTROPHOMONAS MALTOPHILIA; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 33847726612     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Bottone EJ, Reitano M, Janda JM, Troy K, Cuttner J, Pseudomonas maltophilia exoenzyme activity as correlate in pathogenesis of ecthyma gangrenosum. J Clin Microbiol 1986;24:995-7.
2. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998;11:57-80.
3. Vartivarian SE, Papadakis KA, Palacios JA, Manning JT Jr, Anaissie EJ. Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum. Ann Intern Med 1994;121:969-73.
4. Moser C, Jonsson V, Thomsen K, Albrectsen J, Hansen MM, Prag J. Subcutaneous lesions and bacteraemia due to Stenotrophomonas maltophilia in three leukaemic patients with neutropenia. Br J Dermatol 1997;136:949-52.
5. Sakhnini E, Weissmann A, Oren I. Fulminant Stenotrophomonas maltophilia soft tissue infection in immunocompromised patients: an outbreak transmitted via tap water. Am J Med Sci 2002;323:269-72.
6. Villarino ME, Stevens LE, Schable B, Mayers G, Miller JM, Burke JP, et al. Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. Infect Control Hosp Epidemiol 1992;13:201-6.
7. VanCouwenberghe CJ, Farver TB, Cohen SH. Risk factors associated with isolation of Stenotrophomonas (Xanthomonas)maltophilia in clinical specimens. Infect Control Hosp Epidemiol 1997;18:316-21.
8. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990;69:296-306.
9. Muder RR, Harris AP, Muller S, Edmond M, Chow JW, Papadakis K, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective multicenter study of 91 episodes. Clin Infect Dis 1996;22:508-12.
10. Morrison AJ Jr, Hoffmann KK, Wenzel RP. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol 1986;24:52-5.